FDA Investigator Karishma G Gopaul
Karishma G Gopaul has inspections in 1 countries as of 12 Jan 2024. Karishma G Gopaul has collaborated with a combined 1920 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
12 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Addam S Reynolds,
Adena S Yau,
Adetutu M Gidado,
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Amy M Codella,
Amy M Cramer,
Annemarie Bodnar,
Arduino Frankovic,
Ashutosh Rao, PhD,
Barbara Jwilimczyk Macri,
Bijoy Panicker,
Charisse K Green,
Daniel J Grabicki,
David A Oluwo,
David R Delucia,
Demitria J Xiradakis,
Donald C Obenhuber, PhD,
Dongping Dai, PhD,
Douglas C Kovacs,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Emmanuel J Ramos,
Felix Maldonado,
Ferderick Razzaghi,
Frederick Razzaghi,
Gam S Zamil,
Gary J Lehr,
Helen Verdel,
Himanshu Gupta, PhD,
Jacqueline S Warner,
James A Liubicich,
James M Mason,
James R Birkenstamm,
Janet A Rajan,
Jay B Shah,
Jill M Sooter,
Jill Mielziner,
Jogy George,
Jonah S Ufferfilge,
Jose Acruz Gonzalez,
Jose M Cayuela,
Jose O Hernandez,
Josh Renzon Ramilo,
Juliana M Badalucco,
Junho Pak,
Justine Tomasso,
Karen E D'orazio,
Karishma Gopaul,
Kelli F Dobilas,
Kenneth H Williams,
Kim Lthomas Cruse,
Kim Thomasc Rice,
Ko U Min,
Kristy A Zielny,
Larry Johnson,
Lata C Mathew, PhD,
Lauren L Vajo,
Lawrence R Johnson,
Lawrence W Farina,
Li Li,
Marea K Harmon,
Margaret M Sands,
Margaret Sand,
Maria Estrella,
Matthew A Spataro,
Meredith L Sheridan,
Michael R Klapal,
Michael Serrano,
Mindy M Chou,
Morea K Harmen,
Nancy F Scheraga,
Nancy M Espinal,
Nancy Sheraga,
Neil J Bonzagni, PhD MPH,
Nerizza B Guerin,
Nicholas A Violand,
Parul M Patel,
Paul L Bellamy,
Paul Mouris,
Peter Abel,
Peter Caparelli,
Peter R Caparelli,
Pushpa S Jayasekara,
Rachael A Moliver,
Raihan A Chowdhury,
Regina T Brown,
Robert C Steyert,
Rochelle K Kimmel,
Ronald Ifraimov,
Russell J Glapion,
Saleem A Akhtar,
Samir C Gala,
Sandra A Boyd,
Sayyem H Akbar,
Sean G Casey,
Sena G Dissmeyer,
Shirley S Wen,
Sony Mathews,
Srinivas R Chennamaneni, PhD,
Tara G Bizjak,
Tara K Carmody,
Tara R Gooen,
Thomas J Mooney,
Uduak M Inokon,
Unnee Ranjan,
Victoria Spivak,
Vivin George,
Xikui Chen (nmi), PhD,
Yvesna C Blaise
Karishma G Gopaul's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2023 | FDA 483 | Sciarra Laboratories, Inc. - Form 483, 2023-08-07 |
June, 2023 | FDA 483 | Renaissance Lakewood LLC - Form 483, 2023-06-06 |
September, 2023 | FDA 483 | InvaGen Pharmaceuticals, Inc - Form 483, 2023-09-19 |
August, 2023 | FDA 483 | Accuon Labs Inc. - Form 483, 2023-08-31 |
January, 2023 | FDA 483 | Novel Laboratories, Inc. - Form 483, 2023-01-13 |
March, 2023 | FDA 483 | EzriCare, LLC. - Form 483, 2023-03-21 |
September, 2022 | FDA 483 | ScieGen Pharmaceuticals, INC. - Form 483, 2022-09-02 |
June, 2023 | EIR | Renaissance Lakewood LLC - EIR, 2023-06-06 |
March, 2023 | FDA 483 | Maimonides Medical Center - Pharmacy - Form 483, 2023-03-09 |
November, 2022 | FDA 483 | Amneal Pharmaceuticals, LLC - Form 483, 2022-11-18 |
August, 2022 | FDA 483 | Fougera Pharmaceuticals Inc. - Form 483, 2022-08-10 |
January, 2024 | FDA 483 | Pharmalogic New York City, LLC - Form 483, 2024-01-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more